Literature DB >> 31289957

Frequency and predictors of detecting early locoregional recurrence/disease progression of oral squamous cell carcinoma with high-risk factors on imaging tests before postoperative adjuvant radiotherapy.

Yuichi Kibe1, Naoki Nakamura2, Hirofumi Kuno3, Takashi Hiyama3, Ryuichi Hayashi4, Sadamoto Zenda1, Atsushi Motegi1, Hidehiro Hojo1, Masaki Nakamura1, Takaki Ariji1, Hajime Oyoshi1, Tetsuo Akimoto1.   

Abstract

BACKGROUND: To clarify the frequency and predictors of detecting early locoregional recurrence/disease progression (LR/DP) during the interval between surgery and postoperative adjuvant radiotherapy with/without chemotherapy in patients with oral squamous cell carcinoma.
METHODS: Data on 65 patients who had undergone the initial radical surgery for previously untreated oral squamous cell carcinoma which were scheduled to receive adjuvant radiotherapy with/without chemotherapy were reviewed.
RESULTS: Of the 65 patients, 63 (97%) were margin-positive/close and/or extracapsular extension-positive (hereinafter, high-risk factors). Eighteen (28%) patients had abnormal findings suggestive of LR/DP on postoperative imaging. Fifteen (23%) patients were diagnosed with LR/DP and treatment policy was changed. Univariate and multivariate analyses revealed higher frequencies of abnormal findings suggestive of LR/DP (univariate/multivariate analysis, p = 0.020/0.036), diagnosing of LR/DP, and changing the treatment policy (univariate/multivariate analysis, p = 0.042/0.046), among the patients who underwent postoperative diagnostic imaging tests or radiotherapy-planning contrast-enhanced (CE) CT without diagnostic imaging tests as compared with those who underwent radiotherapy-planning non-CECT without such tests.
CONCLUSION: The frequency of detecting of early LR/DP before postoperative adjuvant treatment in oral squamous cell carcinoma patients with high-risk factors was high. Furthermore, postoperative diagnostic imaging tests and radiotherapy-planning CECT may be useful to detect early LR/DP in oral squamous cell carcinoma patients before postoperative adjuvant therapy.

Entities:  

Keywords:  Adjuvant radiotherapy; Oral; Postoperative; Recurrence; Squamous cell carcinoma; Surgery

Mesh:

Year:  2019        PMID: 31289957     DOI: 10.1007/s10147-019-01479-x

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  1 in total

1.  Prognostic importance of DNA from human papillomavirus in patients with oral squamous cell carcinoma.

Authors:  E Pérez-Islas; A García-Carrancá; E Acosta-Gio; N Reynoso-Noverón; H-A Maldonado-Martínez; M Guido-Jiménez; N Sobrevilla-Moreno; M Granados-García; W-B Pérez-Báez; D Vilar-Compte
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2022-03-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.